Dr. Kumar Vedantham

profile_pic

School of Materials Science and Engineering
Nanyang Technological University
Office: N3-01C-10, Seat 14
50 Nanyang Avenue
Singapore 639798

email: kved80@gmail.com

Biography

Dr. Kumar Vedantham earned his doctoral degree in Industrial and Physical Pharmacy from Purdue University, USA. He has prior academic and industry experience in developing formulation and drug delivery systems for controlled release for cardiovascular and ophthalmic applications. Currently he is working as Senior Research Fellow in Materials Science division at NTU. He is interested in working on the interface of biomaterials and drug delivery to meet unmet medical needs. His hobbies include playing tennis, badminton and exploring new cuisine.

Research Interests

Biomaterials, Polymers, Controlled release, Novel drug delivery systems

Publications

Book Chapters
[2]V. Kumar et al., "Future outlook for drug eluting stents", in Drug device combination products: Delivery technologies and applications, L. A, Ed., UK: Woodhead Publishing Limited.
[1]K. I. Keun et al., "Smart drug delivery systems", in Smart materials and structures, M. Schwartz, Ed., CRC.
Refereed Articles
2012
[5]K. Vedantham et al., "Evaluation of a bioresorbable drug delivery system for the treatment of hepatocellular carcinoma", Journal of Biomedical Materials Research Part A, vol. 100A, no. 2, 2012, pp. 432-440. [doi]
[4]K. Vedantham et al., "Development of a probucol-releasing antithrombogenic drug eluting stent", Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol. 100B, no. 4, 2012, pp. 1068-1077. [doi]
2010
[3]G. Acharya et al., "A study of drug release from homogeneous \PLGA\ microstructures", Journal of Controlled Release, vol. 146, no. 2, 2010, pp. 201 - 206. [doi]
[2]A. El-Ghannam et al., "A ceramic-based anticancer drug delivery system to treat breast cancer", Journal of Materials Science: Materials in Medicine, vol. 21, no. 9, 2010, pp. 2701-2710. [doi]
2009
[1]E. Kang et al., "Drug-Eluting Stent for Delivery of Signal Pathway-Specific 1,3-Dipropyl-8-cyclopentyl Xanthine", Molecular Pharmaceutics, vol. 6, no. 4, 2009, pp. 1110-1117. [doi]
Refereed Conference Papers
2011
[5]T. A. A., K. A. D. and V. Kumar, "Drug delivering contact lenses using electrospun nanofibers", in NanoFrontiers, 2011.
[4] Aniket et al., "Engineering surface of orthopedic implants for bactericidal effect and bone bonding enhancement", in Proceedings of the orthopedic research society conference, 2011.
2010
[3]V. Kumar et al., "Evaluation of a novel silicaon-calcium-phosphate composite (SCPC) bioceramic nanoscaffold for local drug therapy in hepatocellular carcinoma (HCC)", in American Association for the study of Liver Diseases (AASLD), 2010.
2008
[2]V. Kumar et al., "Development of anti-thrombogenic drug eluting stent using polymer based on 2-Methacryloyloxyethyl Phosphorylcholine (MPC)", in American Association of Pharmaceutical Scientists (AAPS), 2008.
2004
[1]V. Kumar, H. Priscilla, "Modeling of coarse particle size and shape evolution during attrition in a stirred vessel", in AIChE, 2004.
top